Skip links

Deflazacort

Full Name deflazacort
Drug deflazacort
Manufacturer Upsher Smith (tablets) and Cranbury (oral suspension)
Route of Administration Oral
Site of Care Home
Approved Indication Treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology
Enrollment Form Link Tablets Enrollment Form
Oral suspension Enrollment Form
Phone Number 800-605-1524
Fax Number 877-765-6254